BiotechTube
Noveeda

Noveeda

Prague, Czech Republic· Est.
noveeda.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $800K

Overview

Noveeda is a private, pre-revenue biopharma company developing a pipeline of needle-free emergency medicines. Its lead product, Nasefrin, is an intranasal epinephrine formulation for anaphylaxis, currently in preclinical development with key milestones targeted for 2025-2027. The company combines an experienced international executive team with a scientific R&D center in Czechia to advance its portfolio targeting conditions like poisoning, seizures, and hypoglycemia.

Allergy & ImmunologyToxicologyNeurologyEndocrinology

Technology Platform

Needle-free drug delivery platform focused on reformulating existing emergency medicines into rapid-delivery intranasal and other non-invasive formulations.

Funding History

1
Total raised:$800K
Seed$800K

Opportunities

The global market for needle-free emergency treatments is large and underserved, with high demand for alternatives to injectable products due to needle-phobia and usability issues.
Regulatory support for innovation in life sciences in Europe and the modular application of its platform to multiple acute conditions provide significant expansion potential.

Risk Factors

Key risks include the clinical failure to demonstrate equivalent efficacy and speed to injectable epinephrine, intense competition in the needle-free anaphylaxis space, reliance on securing significant funding for clinical trials, and the regulatory challenges of approving a novel delivery route for a critical emergency medicine.

Competitive Landscape

Noveeda competes in the emerging needle-free anaphylaxis treatment space against companies like ARS Pharmaceuticals (neffy, FDA review pending) and other biotechs developing intranasal or topical epinephrine. It also faces indirect competition from established auto-injector manufacturers (e.g., Viatris, Kaleo) and generic entrants defending their market share.

More companies in Drug Delivery & Formulation →More companies in Czech Republic →